Navigation Links
Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
Date:3/24/2009

SOUTH SAN FRANCISCO, Calif., March 24 /PRNewswire/ -- Catalyst Biosciences, Inc., a pioneer in the discovery and development of engineered proteases known as Alterase(TM) therapeutics, has appointed four new members to the company's Scientific Advisory Board (SAB). Robert J. Fletterick, Ph.D., David Ginsburg M.D., Guy S. Salvesen, Ph.D., and Gregory Stahl, Ph.D., join initial members Shaun Coughlin, M.D., Ph.D., Charles Craik, Ph.D., and James Wells, Ph.D.

"We are pleased to welcome this distinguished group of scientific leaders to the Catalyst Biosciences Scientific Advisory Board," said Dr. Craik, Chairman of the SAB and a founder of Catalyst Biosciences. "We believe that proteases have enormous potential as a broad class of therapeutics, and are excited by the opportunity to provide counsel to Catalyst as the company advances compounds generated from its drug discovery platform into clinical development."

"Our SAB includes world-renowned experts in a diverse group of fields, including proteases, protein engineering, structural biology, cellular enzymatic pathways, blood clotting and clotting disorders, inflammation, the complement system, and immunology," said Dr. Ed Madison, Chief Scientific Officer of Catalyst Biosciences. "We at Catalyst are fortunate to have access to such a wide variety of expertise, which will not only help us add capabilities to our protease drug discovery platform, but also promote our drug development efforts in areas such as hemophilia and related clotting disorders, and age-related macular degeneration and other complement-mediated diseases."

Professor Robert J. Fletterick, Ph.D. is in the Department of Biochemistry at the University of California, San Francisco (UCSF) where he has served as Chair and Vice Chair. He also holds a joint appointment with the Departments of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology at UCSF. Professor Fletterick
'/>"/>

SOURCE Catalyst Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Brown chemists create more efficient palladium fuel cell catalysts
2. New catalyst paves the path for ethanol-powered fuel cells
3. Coalition for the Advancement of Medical Research Releases New White Paper, Catalyst for Cures: Embryonic Stem Cell Research
4. Eurotech Catalyst Module Awarded to Allen Organ Company From Arrow Electronics
5. PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time
6. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
7. Catalyst Pharmaceutical Partners, Inc. Announces a $4.5 Million Registered Direct Common Stock Offering
8. NIST and partners identify tiny gold clusters as top-notch catalysts
9. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
10. Controlling the size of nanoclusters: First step in making new catalysts
11. Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... CA (PRWEB) January 15, 2014 ... research solutions, today announced that Lupin Limited, one of ... Freeslate’s CM Protégé PharmD System for high ... Mumbai, India, is focused on a wide range of ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have scheduled a ... EST (11am PST), “Natural Language Processing: Converting Raw Data ... can turn raw, heterogeneous data into actionable knowledge to ... webinar will last approximately one hour. , Synopsis: Big ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging ... to serve the wound care market. , Free report ... was restructured with a seasoned management team and Board, ...
(Date:1/14/2014)... January 14, 2014 In recent years, ... and methods in product development and promotion has led ... This mistrust, fueled by concerns about the insidious impact ... reports of spectacular fines to the world’s biggest pharmas ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... , , LONDON , ... in a challenging year with a return to,sales growth for the first time ... CEO Andrew Witty also announced,a reduction in the investment into ... He said: , "Now obviously I don,t like ...
... WASHINGTON , Feb. 4 With most liver cancer ... the 22,000 new cases of liver cancer that are diagnosed each ... close the funding gap for federal viral hepatitis education, screening, and ... today. NVHR made the comments in conjunction with World Cancer ...
... , WASHINGTON , Feb. 3 ... today that Robert W. Musslewhite , Chief Executive Officer, and ... presentations at three upcoming investor conferences. , Mr. Musslewhite and Mr. ... at 1:00 PM EST at the UBS 20th ...
Cached Biology Technology:NVHR: Stop Liver Cancer 'Dead in Its Tracks' By Closing Funding Gap for Viral Hepatitis Education, Screening Programs 2NVHR: Stop Liver Cancer 'Dead in Its Tracks' By Closing Funding Gap for Viral Hepatitis Education, Screening Programs 3The Advisory Board Company to Present at Upcoming Conferences 2
(Date:4/17/2014)... New Rochelle, NY, April 17, 2014The development of stem ... on the ability to characterize stem cell populations based ... Cross have discovered a new marker that is highly ... human umbilical cord blood, which they describe in an ... journal from Mary Ann Liebert, Inc., publishers. The article ...
(Date:4/17/2014)... Marc Andr Gauthier and Professor Luca Razzari of ... been awarded large grants from the John R. ... Innovation (CFI) for the acquisition of state-of-the-art biotech ... added matching grants from the Ministre de l,Enseignement ... de la Technologie (MESRST). These new laboratories will ...
(Date:4/17/2014)... German . ... also provide us with a continuous stream of information about ... sit still in a car the world glides by ... Seemingly without effort, our brain calculates self-motion from this "optic ... a steady gaze during our own movements. Together with biologists ...
Breaking Biology News(10 mins):New state-of-the-art biotech and nanotech equipment for INRS 2How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4
... In the minds of many, Miscanthus x giganteus ... for lignocellulosic bioenergy production. But researchers believe "putting all their ... at the University of Illinois recently reported the first natural ... in Japan. "If M. x giganteus ...
... announced the winners of its second annual CPOW travel ... at the Baltimore Convention Center in Baltimore, Maryland, March ... for Women, has initiated these travel fellowships to increase ... at the Meeting. The recipients of this competitive ...
... The Biophysical Society has announced the winner of ... 55th Annual Meeting at the Baltimore Convention Center in ... meant to encourage participation at the Biophysical Society Annual ... will be honored at a reception on Saturday March ...
Cached Biology News:New Miscanthus hybrid discovery in Japan could open doors for biofuel industry 2New Miscanthus hybrid discovery in Japan could open doors for biofuel industry 3Biophysical Society announces winners of 2011 CPOW Travel Awards 2Biophysical Society announces winners of 2011 Minority Travel Awards 2
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Request Info...
Biology Products: